News item 2/2016 (Lisbon, 04.02.2016) Representatives of the Justice Affairs Directorate of the General Secretariat of the Council of the EU will visit the EMCDDA on 4 February where they will meet the agency’s Director Alexis Goosdeel... Read more >>
(Lisbon, 25.01.2016) The EMCDDA Director will be presenting to members of the Committee for Civil Liberties, Justice and Home Affairs (LIBE) highlights from the EMCDDA strategy and work programme 2016–18 and the 2016... Read more >>
News release No 1/2016 (Lisbon, 18.01.2016) Between 6 000 and 8 000 drug-induced deaths are reported in Europe every year, with opioids, such as heroin, found in most overdose cases. Yet with adequate intervention, using the overdose-reversal... Read more >>
Fact sheet 2/2016 (Lisbon, 08.01.2016) This year the University Institute of Lisbon (ISCTE-IUL) and the EMCDDA will be hosting the fifth European drugs summer school (EDSS) from 27 June to 8 July. Registration opens today...
Read more >>
Fact sheet 1/2016 (Lisbon, 04.01.2016) Alexis Goosdeel (Belgium) took up the post of EMCDDA Director on 1 January 2016, having been formally appointed to the position by the agency’s Management Board in October 2015 for a five-year term.
Read more >>
News release 11/2015) (Lisbon, 04.12.2015) The Management Board held elections today for a new Chair and Vice-Chair. Laura d’Arrigo (France) was elected Chair and Franz Pietsch (Austria) Vice-Chair.
Read more >>
News release 10/2015 (Lisbon, 27.11.2015) The co-existence of mental illness and psychoactive drug or other substance use problems — otherwise known as ‘comorbidity’ or ‘dual diagnosis’ — is an issue which has been on the radar of the EU... Read more >>
Fact sheet No 10/2015 (Lisbon, 24.11.2015) Representatives of candidate, potential candidate and neighbouring countries of the EU are joining members of the EMCDDA’s Reitox network in Lisbon today for the kick-off of the agency’s fourth... Read more >>
News release No 9/2015 (Lisbon, 20.10.2015) Europe has responded to rising concerns over the use of two new drugs by subjecting them to ‘control measures and criminal penalties’ throughout the Union. The implementing decision of the Council of... Read more >>
Fact sheet 8/2015 (Lisbon, 09.10.2015) The EU drugs agency (EMCDDA) is co-hosting next week in Ascona, Switzerland, the second international conference on wastewater analysis: ‘Testing the waters 2015’. Read more >>
(Lisbon, 28.09.2015) The Council conclusions set out 16 standards that represent a minimum benchmark of quality for interventions in: drug use prevention, risk and harm reduction, treatment, social integration and... Read more >>
News release 8/2015 (Lisbon, 22.09.2015) The winners of the 2015 EMCDDA scientific paper award will gather in Lisbon on 23 September for the fifth annual paper award ceremony hosted by the EU agency.
Read more >>
News release 6/2015 (Lisbon, 10.09.2015) Alexis Goosdeel (Belgium) was selected today to become the new Director of the Lisbon-based European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Following a public recruitment procedure... Read more >>
Feature article No 1/2015 (Lisbon, 02.09.2015) This year, the EMCDDA commemorates 20 years of monitoring the drugs problem in Europe. EMCDDA Director Wolfgang Götz reflects on this important milestone.
Read more >>
Fact sheet No 6/2015 (Lisbon, 28.07.2015) The European Union and Armenia will cooperate more actively on monitoring the drug phenomenon in future, thanks to a Memorandum of Understanding (MoU) signed today in Yerevan between the EU drugs... Read more >>
(Lisbon, 26.06.2015) Alexis Goosdeel, EMCDDA Head of unit for Reitox and international cooperation, is in Nicosia today to receive an award from the national drug coordination committee, the Cyprus Antidrug Council, for... Read more >>
News release No 5/2015 (Lisbon, 25.06.2015) Drug problems often emerge, and are most acutely felt, in urban environments, making Europe’s cities a valuable observation window on new drug trends. In its latest report — released today ahead of... Read more >>
(Lisbon, 09.06.2015) The latest developments in monitoring and responding to new psychoactive substances (NPS/'new drugs') were discussed at the 15th annual meeting of the Reitox Early Warning System (EWS) network, held... Read more >>
News release No 4/2015 (Lisbon, 04.06.2015) Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and 'new drugs' scene, are among the issues highlighted in this year's... Read more >>
News release No 3/2015 (Lisbon, 21.04.2015) Providing effective treatment for those with cannabis use disorders is likely to become a matter of growing importance in European drug policy. This is according to the EU drugs agency (EMCDDA) today... Read more >>
News release No 2/2015 (Lisbon, 15.04.2015) What are the latest drug market trends and what are the factors driving them? What are the most recent developments in drug prevention, treatment and policy? How many new drugs were detected in... Read more >>
Fact sheet No 5/2015 (Lisbon, 23.03.2015) The EU drugs agency (EMCDDA) publishes today its first overview of the drug situation in the Western Balkans. The report describes a region facing a complex array of drug use problems and associated... Read more >>
News item 8/2015 (Lisbon, 13.03.2015) Harmful and hazardous alcohol use is one of the main causes of premature deaths and avoidable diseases in the EU today. Highlighting the importance of this issue, the European Commission is funding,... Read more >>
(Lisbon, 12.03.2015) The EMCDDA is participating this week in the 7th Conference of the South Eastern European Adriatic (SEEA) Addiction Treatment Network and the 14th SEEA-net Symposium on Addictive Behaviours. Alexis... Read more >>
News item No 8/2015 (Lisbon, 09.03.2015) The United Nations Commission on Narcotic Drugs (CND), the central UN policy-making body in drug-related matters, opens its 58th session in Vienna th Read more >>
News release No 1/2015 (Lisbon/Vienna, 09.03.2015) Among the public health concerns highlighted in the report are new synthetic opioids — often highly potent and sold as heroin to unsuspecting users — posing a high risk of overdose. Three of the five... Read more >>